Skip to Main Content
Skip to left navigation

Glaucoma Research Foundation

Shaffer Grants for Innovative Glaucoma Research are $60,000, one-year grants awarded to scientists and clinicians to fund projects that support new high-impact clinical, epidemiological and laboratory research based on our strategic research goals. 

Researchers interested in applying for a Shaffer Grant must first submit a Preliminary Proposal for consideration, accepted annually from June 1 to July 15. We accept proposals from all countries.

Applicants will be notified about the status of their proposals by August and those approved to submit a full grant application will receive further instructions.

Grant applicants must possess a graduate degree and NOT have received a Shaffer Grant within the prior three years.

Grant recipients agree to:

  • Acknowledge Glaucoma Research Foundation (GRF) in papers and abstracts resulting from GRF-funded research and forward copies of each publication to GRF.
  • Provide a final progress report and pdf poster summarizing the results of the project. 
  • Submit a financial statement at the end of the grant cycle.
  • Return to Glaucoma Research Foundation any unexpended funds at the end of the grant cycle.

Failure to deliver the above documents may result in disqualification of future grant submissions.

When completing your application, please indicate which of the following six areas is the primary focus of your grant.

  • Genetics/Genomics
    • Proposals related to:
      • identifying glaucoma-related genes; or,
      • improving understanding and/or treatment for pediatric/congenital/juvenile glaucomas; or,
      • describing how genetic variants influence glaucoma risk and/or progression
  • Neuroprotection/Regeneration/Enhancement
    • Proposals related to:
      • exploring the mechanisms that lead to retinal ganglion cell (RGC) degeneration in glaucoma
      • prolonging RGC function and survival
      • encouraging RGC axon regrowth
  • Therapeutics/Drug Delivery
    • Proposals related to:
      • developing new molecules or delivery systems that improve upon current standard of care
      • engineering new mechanisms of therapeutic delivery
  • IOP Regulation/Outflow
    • Proposals related to:
      • exploring cellular and molecular mechanisms involved in aqueous humor outflow pathways
      • creation of novel preclinical models to explore intraocular pressure (IOP)-lowering treatments
      • improving ways to lower IOP
  • Immunology/Glia
    • Proposals related to:
      • investigating how neuroinflammation and "support cells" like astrocytes and microglia contribute to the death of RGC
      • exploring role of glial activation in glaucomatous neurodegeneration
  • Clinical/Epidemiology
    • Proposals related to:
      • using outcomes data to determine risk factors and developing tools to accurately detect and monitor glaucoma progress
      • standardizing tools to assess glaucoma phenotypes
      • establishing consensus definitions for disease states

Core Values of Shaffer Grants:

  • Involve people with glaucoma in the design, implementation, and evaluation of programs.
  • Encourage collaboration among experts in many fields of study.
  • Communicate research goals and results to the scientific community and the public.
  • Ensure that new glaucoma treatments maintain or improve individuals’ quality of life.
  • Encourage innovative clinical trial studies and laboratory research.
  • Develop cell and animal models of glaucoma to support research studies.
  • Facilitate and support the development of physician-scientists to advance glaucoma research.

Restrictions

  • Equipment exceeding $12,000 (waivers may be granted on a case-by-case basis)
  • Salaries for principal investigators and co-investigators
  • Projects with overt commercial applications
  • General lab supplies used for daily purposes such as swabs, gloves, etc.
  • Indirect costs, including overhead

To submit an application, please login or register for an account.

Glaucoma Research Foundation does not accept unsolicited grant applications or applications from for profit corporations. Applications sent to our office will not be reviewed or returned.

For additional information on Glaucoma Research Foundation grant programs, please email us.

NOTE: Emails are generated directly from this site. Please check your SPAM folders and add noreply@mail.smapply.net to your safe sender list to ensure you do not miss any important notifications about your application status.

  • Preliminary proposals and full grant applications submitted on this site that ARE NOT selected for funding will be discarded once notification of status has been sent. 
  • Preliminary proposals and full grant applications submitted on this site that ARE selected for funding will be discarded after one year. 
  • If you would like to retain a copy of your application, please download from your account after submission.
Sign Up